Concepedia

Publication | Open Access

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

DOIFull Paper Access

119

Citations

31

References

2014

Year

Kathleen M. Schmainda, Melissa Prah, Jennifer Connelly, Scott D. Rand, Raymond G. Hoffman, Wade M. Mueller, Mark G. Malkin
Neuro-Oncology

Abstract

Standardized rCBV is predictive of OS and PFS in patients with recurrent high-grade brain tumor treated with bevacizumab.

References

YearCitations

Page 1